Jiang C - Search Results

1

Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study.

Gao J, Zhao J, Jiang C, Chen F, Zhao L, Jiang Y, Li H, Wang W, Wu Y, Jin Y, Da L, Liu G, Zhang Y, Li H, Zhang Z, Jin G, Li Q. Gao J, et al. Among authors: jiang c, jiang y. Support Care Cancer. 2022 Jul;30(7):6225-6232. doi: 10.1007/s00520-022-07067-6. Epub 2022 Apr 21. Support Care Cancer. 2022. PMID: 35449368 Free PMC article. Clinical Trial.

2

Evaluation of a Neurokinin-1 Antagonist in Preventing Multiple-day Cisplatin-induced Nausea and Vomiting.

Li Q, Wang W, Chen G, Deng S, Jiang C, Chen F, Zhao J, Li H, Bai X, Hu Y, Da L, Wu Y, Jin G. Li Q, et al. Among authors: jiang c. Open Med (Wars). 2018 Mar 15;13:29-34. doi: 10.1515/med-2018-0005. eCollection 2018. Open Med (Wars). 2018. PMID: 29577093 Free PMC article.

3

Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting.

Li Q, Wu Y, Wang W, Deng S, Jiang C, Chen F, Zhao J, Li H, Bai X, Hou J, Da L, Zhao L, Gao J, Jin G. Li Q, et al. Among authors: jiang c. Curr Probl Cancer. 2019 Dec;43(6):100462. doi: 10.1016/j.currproblcancer.2019.01.003. Epub 2019 Jan 23. Curr Probl Cancer. 2019. PMID: 30709557 Free article. Clinical Trial.

4

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV.

Jin Y, Jin G, Zhao J, Jiang C, Zhao L, Jiang Y, Chen F, Li H, Wang W, Wu Y, Liu G, Li X, Gu M, Li X, Li Q. Jin Y, et al. Among authors: jiang c, jiang y. Pharmgenomics Pers Med. 2021 Jul 15;14:867-875. doi: 10.2147/PGPM.S317229. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34290520 Free PMC article.

5

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia.

Li Q, Jin G, Jiang C, Zhang Z, Hou J, Zhao J, Chen F, Li Z. Li Q, et al. Among authors: jiang c. Arch Med Sci. 2021 Aug 9;17(5):1440-1446. doi: 10.5114/aoms/141134. eCollection 2021. Arch Med Sci. 2021. PMID: 34522277 Free PMC article. No abstract available.

6

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting.

Jin Y, Li X, Jiang C, Zhao J, Liu G, Li H, Jin G, Li Q. Jin Y, et al. Among authors: jiang c. Int J Gen Med. 2021 Sep 18;14:5879-5892. doi: 10.2147/IJGM.S329257. eCollection 2021. Int J Gen Med. 2021. PMID: 34566427 Free PMC article. Review.

7

Progress in Research on Antitumor Drugs and Dynamic Changes in Skeletal Muscles.

Xu T, Li ZH, Liu T, Jiang CH, Zhang YJ, Li H, Jiang Y, Zhao J, Guo WJ, Guo JY, Wang L, Li JX, Shen J, Jin GW, Zhang ZW, Li QF. Xu T, et al. Front Pharmacol. 2022 Jul 6;13:893333. doi: 10.3389/fphar.2022.893333. eCollection 2022. Front Pharmacol. 2022. PMID: 35873591 Free PMC article. Review.

8

A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting.

Liu G, Jin Y, Jiang Y, Zhao J, Jiang C, Zhang Z, Zhao L, Li H, Chen F, Wang J, Fan H, Li Z, Jia Y, Jin G, Li Q. Liu G, et al. Among authors: jiang c, jiang y. Int J Clin Pract. 2022 Sep 7;2022:5954379. doi: 10.1155/2022/5954379. eCollection 2022. Int J Clin Pract. 2022. PMID: 36128262 Free PMC article. Clinical Trial.

9

Association between Body Composition and Peripheral Neurotoxicity in Cancer Patients from North China Taking Nab-Paclitaxel.

Guo J, Zhao J, Gu M, Hou J, Xu T, Jiang Y, Jiang C, Li H, Li X, Liu G, Zhao L, Jin G, Shi Y, Liu T, Li Z, Zhang Z, Li Q. Guo J, et al. Among authors: jiang c, jiang y. Nutr Cancer. 2023;75(3):805-814. doi: 10.1080/01635581.2022.2156552. Epub 2022 Dec 19. Nutr Cancer. 2023. PMID: 36533716 Clinical Trial.

10

Low Dose Olanzapine in the Prevention and Treatment of Carboplatin Induced Nausea and Vomiting: A Prospective Clinical Randomized Controlled Trial.

An Y, Zhang Z, Gu M, Zhao J, Jiang C, Zhao L, Jiang Y, Li H, Liu G, Jin G, Li Q. An Y, et al. Among authors: jiang c, jiang y. Curr Pharm Des. 2023;29(23):1867-1874. doi: 10.2174/1381612829666230804114538. Curr Pharm Des. 2023. PMID: 37539930 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,710 results

Search Page

Filters